Publication | Open Access

Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications

5-Arylidene-4-thiazolidinone DerivativesMedicinal ChemistryAntioxidant AgentsAldo-keto ReductaseBiochemistryMedicineNatural SciencesDual ActivityPharmacological AgentPharmacotherapyDrug DevelopmentPharmacologyDrug Discovery